IndraLab
Statements
reach
"Thus, the potential influence of baseline radiotherapy treatment on the subsequent improved response to pasireotide LAR therapy cannot be entirely excluded.Ubiquitin-specific protease 8 (USP-8) gene mutational status could be a potential marker of the pasireotide response, as mutant USP8 forms may upregulate SSTR5 transcription [1,17,18]."